Mechanism of Cas9 inhibition by AcrIIA11
Nucleic Acids Research · 22.04.2025 · 53 (8)
DOI: 10.1093/nar/gkaf318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 25.04.2025. Verfasst von Kaylee E Dillard und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biosciences and Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712, United States. Hauptthemen laut MEDLINE: CRISPR-Associated Protein 9, CRISPR-Cas Systems, Bacterial Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Howard Hughes Medical Institute Emerging Pathogens Initiative, Welch Foundation.
Abstract (Originalsprache)
Mobile genetic elements evade CRISPR–Cas adaptive immunity by encoding anti-CRISPR proteins (Acrs). Acrs inactivate CRISPR–Cas systems via diverse mechanisms but generally coevolve with a narrow subset of Cas effectors that share high sequence similarity. Here, we demonstrate that AcrIIA11 inhibits Streptococcus pyogenes (Sp), Staphylococcus aureus (Sa), and Francisella novicida (Fn) Cas9s in vitro and in human cells. Single-molecule imaging reveals that AcrIIA11 hinders SaCas9 target search by reducing its diffusion on nonspecific DNA. DNA cleavage is inhibited because the AcrIIA11:SaCas9 complex binds to protospacer adjacent motif (PAM)-rich off-target sites, preventing SaCas9 from reaching its target. AcrIIA11 also greatly slows down DNA cleavage after SaCas9 reaches its target site. A negative-stain electron microscopy reconstruction of an AcrIIA11:SaCas9 RNP complex reveals that the heterodimer assembles with a 1:1 stoichiometry. Physical AcrIIA11–Cas9 interactions across type IIA and IIB Cas9s correlate with nuclease inhibition and support its broad-spectrum activity. These results add a kinetic inhibition mechanism to the phage-CRISPR arms race.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biosciences and Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712, United States.
- Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
- Center for Systems and Synthetic Biology, University of Texas at Austin, Austin, TX 78712, United States.
ORCID-Profile: Ilya J Finkelstein
Förderung
- NIGMS NIH HHS
- Howard Hughes Medical Institute Emerging Pathogens Initiative
- Welch Foundation
- University of Texas Southwestern Medical Center
- NIAID NIH HHS
- NIH
- Searle Scholars Award
Zitieren
APA
Dillard, K. E., Zhang, H., Dubbs, L. Z., Chou, C. W., Terrace, C., Javanmardi, K., Kim, W., Forsberg, K. J., & Finkelstein, I. J. (2025). Mechanism of Cas9 inhibition by AcrIIA11. Nucleic Acids Research, 53(8). https://doi.org/10.1093/nar/gkaf318
Vancouver
Dillard KE, Zhang H, Dubbs LZ, Chou CW, Terrace C, Javanmardi K, et al. Mechanism of Cas9 inhibition by AcrIIA11. Nucleic Acids Research. 2025;53(8). doi:10.1093/nar/gkaf318
BibTeX
@article{Dillard2025,
author = {Dillard, Kaylee E and Zhang, Hongshan and Dubbs, Lianne Z and Chou, Chia-Wei and Terrace, Cynthia and Javanmardi, Kamyab and Kim, Wantae and Forsberg, Kevin J and Finkelstein, Ilya J},
title = {Mechanism of Cas9 inhibition by AcrIIA11},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {8},
doi = {10.1093/nar/gkaf318}
}
EUVIMED